Save your place

Sign in to WhoBought

Please try again later.

Lantern Pharma Inc. (LTRN) institutional ownership

Latest close $2.87 Jul 23, 2026
Market cap$51M 52-week range SectorHealthcare
Funds holding · Q1 2026
23
reported LTRN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
11 buyers · 12 sellers

Lantern Pharma Inc. (LTRN) price and institutional activity

Dates

Q1 2026

$0 bought by 11 investors
Cm Management, LLCGeode +9 more
$0 sold by 12 investors
Bios Capital Management, LPCitadel Advisors LLC +10 more
Bought Sold Totals per quarter; hover a bar for the names.

Lantern Pharma Inc. (LTRN) institutional activity · 23

Investor Type Est. change Change Δ Own Date
Bios Capital Management, LP · Reduced
Change −145K Date Q1 2026
Bios Capital Management, LP Reduced· Q1 2026 −145K Q1 2026
Citadel Advisors LLC Exited· Q1 2026 −33K −100.0% Q1 2026
Susquehanna International Group, LLP · Exited
Change −29K Δ Own −100.0% Date Q1 2026
Susquehanna International Group, LLP Exited· Q1 2026 −29K −100.0% Q1 2026
Cm Management, LLC · Added
Change +25K Date Q1 2026
Cm Management, LLC Added· Q1 2026 +25K Q1 2026
Geode · Added
Change +15K Date Q1 2026
Geode Added· Q1 2026 +15K Q1 2026
Westside Investment Management, Inc. · Added
Change +14K Date Q1 2026
Westside Investment Management, Inc. Added· Q1 2026 +14K Q1 2026
Newedge Advisors, LLC · Reduced
Change −11K Date Q1 2026
Newedge Advisors, LLC Reduced· Q1 2026 −11K Q1 2026
Renaissance Technologies LLC Added· Q1 2026 +6K +5.1% Q1 2026
Bank of New York Mellon Corp · Reduced
Change −5K Date Q1 2026
Bank of New York Mellon Corp Reduced· Q1 2026 −5K Q1 2026
Group One Trading LLC · Reduced
Change −4K Date Q1 2026
Group One Trading LLC Reduced· Q1 2026 −4K Q1 2026
Tower Research Capital LLC (trc) · Added
Change +3K Date Q1 2026
Tower Research Capital LLC (trc) Added· Q1 2026 +3K Q1 2026
Simplex Trading, LLC · Reduced
Change −2K Date Q1 2026
Simplex Trading, LLC Reduced· Q1 2026 −2K Q1 2026
Horizon Kinetics Asset Management LLC · Reduced
Change −1K Date Q1 2026
Horizon Kinetics Asset Management LLC Reduced· Q1 2026 −1K Q1 2026
Dimensional · Reduced
Change −1K Date Q1 2026
Dimensional Reduced· Q1 2026 −1K Q1 2026
BlackRock · Added
Change +1K Date Q1 2026
BlackRock Added· Q1 2026 +1K Q1 2026
Data through Q1 2026 · filed Jun 3, 2026
15 of 23

Famous investor activity in Lantern Pharma Inc. (LTRN)

Lantern Pharma Inc. (LTRN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Schalop Lee Troy · Director Buy +$100K
Price $2.06 Qty +49K Owned 49K Trade date May 12, 2026 Filed date May 14, 2026
Schalop Lee Troy Director Buy $2.06 +49K +$100K 49K May 12, 2026 May 14, 2026
Schalop Lee Troy · Director Other Form 4 event (P, derivative) -49K
Owned 49K Trade date May 12, 2026 Filed date May 14, 2026
Schalop Lee Troy Director Other Form 4 event (P, derivative) -49K 49K May 12, 2026 May 14, 2026
Keyser D. Jeffrey · Director Buy +$100K
Price $2.06 Qty +49K Owned 94K Trade date May 12, 2026 Filed date May 14, 2026
Keyser D. Jeffrey Director Buy $2.06 +49K +$100K 94K May 12, 2026 May 14, 2026
Keyser D. Jeffrey · Director Other Form 4 event (P, derivative) -49K
Owned 49K Trade date May 12, 2026 Filed date May 14, 2026
Keyser D. Jeffrey Director Other Form 4 event (P, derivative) -49K 49K May 12, 2026 May 14, 2026
Keyser D. Jeffrey · Director 2 operations 54K
Owned 25K Trade date Jan 9, 2026 Filed date Jan 13, 2026
Keyser D. Jeffrey Director 2 operations 54K 25K Jan 9, 2026 Jan 13, 2026
Maccecchini Maria-Luisa · Director 2 operations 46K
Owned 21K Trade date Jan 9, 2026 Filed date Jan 13, 2026
Maccecchini Maria-Luisa Director 2 operations 46K 21K Jan 9, 2026 Jan 13, 2026
Chandru Vijay · Director 2 operations 42K
Owned 17K Trade date Jan 9, 2026 Filed date Jan 13, 2026
Chandru Vijay Director 2 operations 42K 17K Jan 9, 2026 Jan 13, 2026
Schalop Lee Troy · Director 2 operations 43K
Owned 25K Trade date Jan 9, 2026 Filed date Jan 13, 2026
Schalop Lee Troy Director 2 operations 43K 25K Jan 9, 2026 Jan 13, 2026
Silberstein David S. · Director 2 operations 42K
Owned 25K Trade date Jan 9, 2026 Filed date Jan 13, 2026
Silberstein David S. Director 2 operations 42K 25K Jan 9, 2026 Jan 13, 2026
Margrave David R. · Officer Grant (A) 20K
Owned 20K Trade date Dec 18, 2025 Filed date Dec 22, 2025
Margrave David R. Officer Grant (A) 20K 20K Dec 18, 2025 Dec 22, 2025
Bhatia Kishor G. · Officer Grant (A) 10K
Owned 10K Trade date Dec 18, 2025 Filed date Dec 22, 2025
Bhatia Kishor G. Officer Grant (A) 10K 10K Dec 18, 2025 Dec 22, 2025
Schalop Lee Troy · Director Grant (A) 5K
Owned 5K Trade date Aug 19, 2025 Filed date Aug 20, 2025
Schalop Lee Troy Director Grant (A) 5K 5K Aug 19, 2025 Aug 20, 2025
12 of 12

Lantern Pharma Inc. (LTRN) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Prophase Labs, Inc. 910K
% of shares outstanding 8.4% Filing date Nov 21, 2022
Prophase Labs, Inc. 910K 8.4% Nov 21, 2022
Thomas A. Satterfield, Jr. 975K
% of shares outstanding 7.6% Filing date Jul 23, 2026
Thomas A. Satterfield, Jr. 975K 7.6% Jul 23, 2026
2 of 2

Lantern Pharma Inc. (LTRN) ownership FAQ

Who owns LTRN?

23 reporting institutions disclosed LTRN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.